摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

4-hydroxy-3-methoxy-benzoic acid allyl ester | 99865-83-5

中文名称
——
中文别名
——
英文名称
4-hydroxy-3-methoxy-benzoic acid allyl ester
英文别名
4-Hydroxy-3-methoxy-benzoesaeure-allylester;allyl 4-hydroxy-3-methoxybenzoate;prop-2-enyl 4-hydroxy-3-methoxybenzoate
4-hydroxy-3-methoxy-benzoic acid allyl ester化学式
CAS
99865-83-5
化学式
C11H12O4
mdl
——
分子量
208.214
InChiKey
IPZQQTRITUSPSU-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 沸点:
    349.0±27.0 °C(Predicted)
  • 密度:
    1.170±0.06 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    2.4
  • 重原子数:
    15
  • 可旋转键数:
    5
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.18
  • 拓扑面积:
    55.8
  • 氢给体数:
    1
  • 氢受体数:
    4

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    4-hydroxy-3-methoxy-benzoic acid allyl ester吡啶三氯氧磷 作用下, 生成 3,3',3''-trimethoxy-4,4',4''-phosphoryltrioxy-tri-benzoic acid triallyl ester
    参考文献:
    名称:
    Yanagawa et al., 1957, vol. 8, p. 69,74
    摘要:
    DOI:
  • 作为产物:
    描述:
    香草酸硫酸 作用下, 以75%的产率得到4-hydroxy-3-methoxy-benzoic acid allyl ester
    参考文献:
    名称:
    Bi-aromatic esters, a process for their preparation and their use in
    摘要:
    双芳香酯的化学式为##STR1##其中R.sub.1代表H,OH,--CH.sub.3,--CH.sub.2 OH,--CH(OH)CH.sub.3,--COOR.sub.9,##STR2##或SO.sub.2 R.sub.10;R.sub.9代表H,C.sub.1 -C.sub.6烷基或单或多羟基烷基;R.sub.10代表OH,C.sub.1 -C.sub.6烷基或##STR3##r'和r"代表H,C.sub.1 -C.sub.6烷基,芳基,芳基烷基,单或多羟基烷基,或r'和r"一起形成杂环;R.sub.2代表H,C.sub.1 -C.sub.6烷基,OR.sub.9,F或--CF.sub.3;R.sub.3,R.sub.4和R.sub.5代表H,F,OH,--CH.sub.3,--OCH.sub.3,--CF.sub.3,--COOH或--CH.sub.2 OH;R.sub.6和R.sub.8代表H,α-取代的C.sub.3 -C.sub.15烷基,α,α'-二取代的C.sub.4 -C.sub.12烷基,C.sub.3 -C.sub.12环烷基,C.sub.5 -C.sub.12单环或多环环烷基,其连接碳为三取代,--SR.sub.11,--SO.sub.2 R.sub.11或--SOR.sub.11;R.sub.11代表C.sub.1 -C.sub.6烷基或环烷基;R.sub.6和R.sub.8不能同时代表H;R.sub.7代表H,C.sub.1 -C.sub.6烷基,烯烃基,烯烃氧基,OR.sub.12或SR.sub.13;R.sub.12代表H,C.sub.1 -C.sub.6烷基或烯烃基;R.sub.3代表H,C.sub.1 -C.sub.6烷基或芳基;但有一个例外,当R.sub.1代表##STR4##且R.sub.2代表H时:(i)要么R.sub.3和R.sub.4不是H或--CH.sub.3,(ii)或者R.sub.7不是OR.sub.12且R.sub.6或R.sub.8是具有超过7个碳原子的环烷基,(iii)或者R.sub.7是OR.sub.12但R.sub.6和R.sub.8不是H,(iv)或者R.sub.7是OR.sub.12但R.sub.5不是H。这些双芳香酯在人类和兽医药物以及化妆品配方中被使用。
    公开号:
    US05200550A1
点击查看最新优质反应信息

文献信息

  • A linker for amidines in solid phase synthesis
    作者:Patrick Roussel、Mark Bradley、Ian Matthews、Peter Kane
    DOI:10.1016/s0040-4039(97)01013-7
    日期:1997.7
    A range of linkers for the important amidine pharmacophore, cleavable using acid or light have been developed for use in library synthesis. The utility of these linkers is demonstrated by the solid phase synthesis of the Novartis (ex-Ciba) phase II compound CGS-25019C.
    已经开发了重要的am药药基团的一系列连接基,可使用酸或光将其裂解以用于文库合成。诺华(Ciba前)II期化合物CGS-25019C的固相合成证明了这些接头的效用。
  • [EN] BIOLOGICALLY ACTIVE POLYMERIC COMPOUNDS, THEIR METHODS OF PRODUCTION AND USES THEREOF<br/>[FR] COMPOSÉS POLYMÈRES BIOLOGIQUEMENT ACTIFS, LEURS PROCÉDÉS DE PRODUCTION ET LEURS UTILISATIONS
    申请人:SUNREZ CORP
    公开号:WO2009079408A1
    公开(公告)日:2009-06-25
    Described herein are biologically active compounds, methods for making such compounds, wherein said methods comprise reacting a phenolic residue with an amine to form an biologically active polymeric material
    本文描述了具有生物活性的化合物,制备这些化合物的方法,其中所述方法包括将残基与胺反应形成具有生物活性的聚合材料。
  • Design and Synthesis of a Novel and Potent Series of Inhibitors of Cytosolic Phospholipase A<sub>2</sub> Based on a 1,3-Disubstituted Propan-2-one Skeleton
    作者:Stephen Connolly、Colin Bennion、Sarah Botterell、Pamela J. Croshaw、Catherine Hallam、Kim Hardy、Paul Hartopp、Clive G. Jackson、Sarah J. King、Louise Lawrence、Antonio Mete、David Murray、David H. Robinson、Gillian M. Smith、Linda Stein、Iain Walters、Edward Wells、W. John Withnall
    DOI:10.1021/jm011050x
    日期:2002.3.1
    Using knowledge of the substrate specificity of cPLA(2) (phospliolipases A(2)), a novel series of inhibitors of this enzyme were designed based upon a three point model of inhibitor binding to the enzyme active site comprising a lipophilic anchor, an electrophilic serine "trap", and an acidic binding moiety. The resulting 1,3-diheteroatom-substituted propan-2-ones were evaluated as inhibitors of cPLA2 in both aggregated bilayer and soluble substrate assays. Systematic variation of the lipophilic, electrophilic, and acidic groups revealed a well-defined structure-activity relationship against the enzyme. Optimization of each group led to compound 22 (ARC70484XX), which contains a decyloxy lipophilic side chain, a 1,3-diaryloxypropan-2-one moiety as a unique serine trap, and a benzoic acid as the acidic binding group. AR-C70484XX was found to be among the most potent in vitro inhibitors of cPLA2, described to date being more than 20-fold more active against the isolated enzyme (IC50 = 0.03 muM) than the standard CPLA(2) inhibitor, arachidonyl trifluoromethyl ketone (AACOCF(3)), and also greater than 10-fold more active than AACOCF3 against the cellular production of arachidonic acid by HL60 cells (IC50 = 2.8 muM).
  • ESTER-FUNCTIONAL POLYSILOXANES AND COPOLYMERS MADE THEREFROM
    申请人:Momentive Performance Materials Inc.
    公开号:EP3164447A1
    公开(公告)日:2017-05-10
  • COMPOSITIONS FOR NEUTRALIZATION AND DECONTAMINATION OF TOXIC CHEMICAL AND BIOLOGICAL AGENTS
    申请人:Puckett Paul M.
    公开号:US20110288360A1
    公开(公告)日:2011-11-24
    Described herein are compositions for neutralization and decontamination of toxic chemical and biological agents. In one embodiment, the subject matter discloses a nontoxic, non-corrosive composition capable of neutralizing and decontaminating toxic chemical and biological agents in a very short period of time. The present subject matter finds utility in a great number of occasions, including, but not limited to, military actions or terrorist attacks where chemical or biological agents are utilized.
查看更多

同类化合物

(βS)-β-氨基-4-(4-羟基苯氧基)-3,5-二碘苯甲丙醇 (S,S)-邻甲苯基-DIPAMP (S)-(-)-7'-〔4(S)-(苄基)恶唑-2-基]-7-二(3,5-二-叔丁基苯基)膦基-2,2',3,3'-四氢-1,1-螺二氢茚 (S)-盐酸沙丁胺醇 (S)-3-(叔丁基)-4-(2,6-二甲氧基苯基)-2,3-二氢苯并[d][1,3]氧磷杂环戊二烯 (S)-2,2'-双[双(3,5-三氟甲基苯基)膦基]-4,4',6,6'-四甲氧基联苯 (S)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (R)富马酸托特罗定 (R)-(-)-盐酸尼古地平 (R)-(-)-4,12-双(二苯基膦基)[2.2]对环芳烷(1,5环辛二烯)铑(I)四氟硼酸盐 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[((6-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[(4-叔丁基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[(3-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-(+)-4,7-双(3,5-二-叔丁基苯基)膦基-7“-[(吡啶-2-基甲基)氨基]-2,2”,3,3'-四氢1,1'-螺二茚满 (R)-3-(叔丁基)-4-(2,6-二苯氧基苯基)-2,3-二氢苯并[d][1,3]氧杂磷杂环戊烯 (R)-2-[((二苯基膦基)甲基]吡咯烷 (R)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (N-(4-甲氧基苯基)-N-甲基-3-(1-哌啶基)丙-2-烯酰胺) (5-溴-2-羟基苯基)-4-氯苯甲酮 (5-溴-2-氯苯基)(4-羟基苯基)甲酮 (5-氧代-3-苯基-2,5-二氢-1,2,3,4-oxatriazol-3-鎓) (4S,5R)-4-甲基-5-苯基-1,2,3-氧代噻唑烷-2,2-二氧化物-3-羧酸叔丁酯 (4S,4''S)-2,2''-亚环戊基双[4,5-二氢-4-(苯甲基)恶唑] (4-溴苯基)-[2-氟-4-[6-[甲基(丙-2-烯基)氨基]己氧基]苯基]甲酮 (4-丁氧基苯甲基)三苯基溴化磷 (3aR,8aR)-(-)-4,4,8,8-四(3,5-二甲基苯基)四氢-2,2-二甲基-6-苯基-1,3-二氧戊环[4,5-e]二恶唑磷 (3aR,6aS)-5-氧代六氢环戊基[c]吡咯-2(1H)-羧酸酯 (2Z)-3-[[(4-氯苯基)氨基]-2-氰基丙烯酸乙酯 (2S,3S,5S)-5-(叔丁氧基甲酰氨基)-2-(N-5-噻唑基-甲氧羰基)氨基-1,6-二苯基-3-羟基己烷 (2S,2''S,3S,3''S)-3,3''-二叔丁基-4,4''-双(2,6-二甲氧基苯基)-2,2'',3,3''-四氢-2,2''-联苯并[d][1,3]氧杂磷杂戊环 (2S)-(-)-2-{[[[[3,5-双(氟代甲基)苯基]氨基]硫代甲基]氨基}-N-(二苯基甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[((1S,2S)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[[((1R,2R)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2-硝基苯基)磷酸三酰胺 (2,6-二氯苯基)乙酰氯 (2,3-二甲氧基-5-甲基苯基)硼酸 (1S,2S,3S,5S)-5-叠氮基-3-(苯基甲氧基)-2-[(苯基甲氧基)甲基]环戊醇 (1S,2S,3R,5R)-2-(苄氧基)甲基-6-氧杂双环[3.1.0]己-3-醇 (1-(4-氟苯基)环丙基)甲胺盐酸盐 (1-(3-溴苯基)环丁基)甲胺盐酸盐 (1-(2-氯苯基)环丁基)甲胺盐酸盐 (1-(2-氟苯基)环丙基)甲胺盐酸盐 (1-(2,6-二氟苯基)环丙基)甲胺盐酸盐 (-)-去甲基西布曲明 龙蒿油 龙胆酸钠 龙胆酸叔丁酯 龙胆酸 龙胆紫-d6 龙胆紫